Rubicon Organics, Inc. (ROMJ) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

14.29 k

Shareholding (Mar 2025)

FII

2.12%

Held by 1 FIIs

DII

97.88%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Flat results in Jun 25

OPERATING CASH FLOW(Y) Lowest at CAD 2.02 MM
DEBT-EQUITY RATIO (HY) Highest at 5.21 %

With ROE of -33.51%, it has a fair valuation with a 0.73 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 30 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.14

Return on Equity

-33.51%

Price to Book

0.70

Revenue and Profits:

Net Sales:

15 Million

(Quarterly Results - Jun 2025)

Net Profit:

1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-28.12%

6 Months

6.98%

1 Year

24.32%

2 Years

-8.0%

3 Years

-28.12%

4 Years

-77.56%

5 Years

-86.89%

Rubicon Organics, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Rubicon Organics Faces Financial Challenges Amid Valuation Adjustment and Loss-Making Status

Rubicon Organics, Inc. has recently experienced an evaluation adjustment, reflecting significant changes in its financial metrics. Key indicators show a low Price to Book Value and negative returns on capital and equity, highlighting the company's ongoing challenges in achieving profitability and operational efficiency amidst shifting market conditions.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

106.96%

EBIT Growth (5y)

3.07%

EBIT to Interest (avg)

-14.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

0.94

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

2.12%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.73

EV to EBIT

-1.93

EV to EBITDA

-2.57

EV to Capital Employed

0.68

EV to Sales

0.46

PEG Ratio

Dividend Yield

ROCE (Latest)

-35.38%

ROE (Latest)

-33.51%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (2.12%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 20.97% vs -12.68% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 366.67% vs 0.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.00",
          "val2": "12.40",
          "chgp": "20.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.50",
          "val2": "-2.60",
          "chgp": "3.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.40",
          "val2": "3.30",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.80",
          "val2": "-0.30",
          "chgp": "366.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-225.70%",
          "val2": "-274.10%",
          "chgp": "4.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 21.45% vs 12.96% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -44.44% vs 53.85% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "48.70",
          "val2": "40.10",
          "chgp": "21.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.00",
          "val2": "-9.30",
          "chgp": "-18.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "13.60",
          "val2": "11.30",
          "chgp": "20.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.60",
          "val2": "-1.80",
          "chgp": "-44.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-293.50%",
          "val2": "-308.60%",
          "chgp": "1.51%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

15.00

12.40

20.97%

Operating Profit (PBDIT) excl Other Income

-2.50

-2.60

3.85%

Interest

0.20

Exceptional Items

4.40

3.30

33.33%

Consolidate Net Profit

0.80

-0.30

366.67%

Operating Profit Margin (Excl OI)

-225.70%

-274.10%

4.84%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 20.97% vs -12.68% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 366.67% vs 0.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

48.70

40.10

21.45%

Operating Profit (PBDIT) excl Other Income

-11.00

-9.30

-18.28%

Interest

1.10

Exceptional Items

13.60

11.30

20.35%

Consolidate Net Profit

-2.60

-1.80

-44.44%

Operating Profit Margin (Excl OI)

-293.50%

-308.60%

1.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 21.45% vs 12.96% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -44.44% vs 53.85% in Dec 2023

All Annual Results

Company CV

About Rubicon Organics, Inc.

Rubicon Organics, Inc.

Pharmaceuticals & Biotechnology

Rubicon Organics Inc is a Canada-based company engaged in cannabis business sector. The Company is a organic cannabis company with operations in Canada, California and Washington. The Company, through its subsidiary Vintages Organic Cannabis Company Inc, is a late-stage applicant under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).

Company Coordinates

Company Details

505 - 744 West Hastings Street , VANCOUVER BC : V6C 1A5

Tel: 1 604 6875744

https://rubiconorganics.com

Registrar Details

Rubicon Organics, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

Flat results in Jun 25

With ROE of -33.51%, it has a fair valuation with a 0.73 Price to Book Value

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Rubicon Organics Faces Financial Challenges Amid Valuation Adjustment and Loss-Making Status

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Rubicon Organics, Inc.

Company Coordinates